AI Longevity Daily
Daily developments in AI, longevity and aging research.
Today’s Summary
A single injection of a gene-editing therapy kept bad cholesterol low in primates for two years.
A short peptide drug improved egg cell maturation quality in aging mice, with similar signals observed in human cells in vitro.
Primate results have not entered human clinical trials — whether they'll replicate in humans remains unknown.🔥 Today’s Top 8 Highlights
1. One Shot, Two Years of Cholesterol Control — Primate Data Is In
Scribe Therapeutics made waves at the American Heart Association (AHA) annual meeting, announcing that a single injection of its experimental gene-editing therapy STX-1150 kept LDL cholesterol (the “bad” kind) at low levels for at least two years in non-human primates. Per Longevity.Technology’s coverage , the company also dropped early data on another candidate, STX-1200, at the same session. All results are still from animal studies — no human clinical trials yet. 🧬
2. Elamipretide Slows Ovarian Aging in Mice 🐭
Published in the peer-reviewed journal Aging Cell, this study found that seven consecutive days of injecting the short peptide Elamipretide into aging mice improved egg cell (oocyte) maturation quality, boosted fertilization rates, and increased litter sizes within one month post-treatment. Elamipretide also showed similar improvement signals in vitro on human oocytes from women over 35 — but the gap between in vitro experiments and real clinical outcomes is still massive. This doesn’t mean the drug can extend the human fertility window just yet.
3. Yogurt and Cheese Don’t Clearly Help Muscle Health in People 50+ 🥛
A cross-sectional analysis of 6,790 Irish adults aged 50 and over found that after controlling for lifestyle and socioeconomic factors, consuming fermented dairy products (yogurt and cheese) showed no consistent association with grip strength, physical performance, or frailty levels. Per News-Medical’s coverage , one analysis even flagged a link between higher intake and elevated odds of low grip strength — though other analyses couldn’t replicate that finding. Cross-sectional studies only capture associations at a single point in time, so causality is off the table. Researchers emphasized the need for longitudinal follow-up.
4. Johns Hopkins Completes Enrollment for Phase 1 Trial Converting Skin Cells to Palm-Like Tissue 🖐️
Johns Hopkins Medicine researchers, backed by NIH funding, partially converted ordinary skin cells into “volar skin” — the tougher, more friction- and pressure-resistant skin found on palms and soles of the feet. Per News-Medical’s report , this Phase 1 trial focused primarily on safety assessment; efficacy data hasn’t been released yet, and specific enrollment numbers and completion details are pending verification from the original source.
5. Rare Genetic Mutation May Protect Against Parkinson’s and Lewy Body Dementia 🧠
Researchers at Oregon Health & Science University identified a rare genetic mutation that may offer protection against Parkinson’s disease and Lewy body dementia — a type of dementia characterized by abnormal protein deposits in the brain. Per News-Medical’s coverage , the current source is abstract-level; specific study design, sample size, and mutation locus are pending verification from the full paper. This does not mean the mutation can be artificially replicated or used therapeutically — not yet.
6. Gut Microbial Metabolites May Reshape Fat Tissue via Wnt Signaling 🦠
This study covered by News-Medical digs into how metabolites produced by gut bacteria influence fat tissue — specifically through the Wnt signaling pathway, a mechanism that controls cell proliferation and differentiation. The abstract notes that when new fat cell generation falls short in adipose tissue, excess energy piles up in aging fat cells, which can trigger inflammation and insulin resistance. Source is abstract-level; study subjects, samples, and specific findings are pending verification from the full paper.
7. Living Arrangements Linked to Mental Health Outcomes in Older Adults 🏠
As multi-generational households become less common, more older adults are living alone or just with a spouse. Per News-Medical’s coverage , this study examined associations between different living arrangements and mental health outcomes in seniors. Source is abstract-level; specific sample, region, measurement metrics, and direction of association are pending full-paper verification. As an observational study, it can only speak to associations — not whether living arrangements directly cause mental health changes.
8. Longevity Omics: A New Review Tries to Unify Multi-Omics and Lifespan Science 📚
A paper titled “The Science of Longevology as Longevity Omics” has been indexed in Europe PMC. Per its index page , it attempts to build a unified systems science framework for healthy longevity, integrating multi-omics (simultaneous analysis of genomic, proteomic, metabolomic, and other biological data layers) with lifespan research. Peer review status is pending verification, and specific findings and methods still need to be confirmed from the full paper.
⚡ Product & Feature Updates
Tiny Health Launches Gut Microbiome Biological Age Score 🦠
Tiny Health, based in Austin, Texas, unveiled two new features at the Eudēmonia Summit: Microbiome Age and Gut-Body Connections. “Microbiome biological age” is an estimation metric — it infers the relative aging level of a person’s gut microbiome by comparing their gut composition against a reference database. It’s not a proven disease-risk predictor. Per Longevity.Technology’s coverage , the service is consumer-facing; the specific algorithm basis and validation studies are pending verification.
⌘ Top Open Source Projects
qlu-lab/SARDINE: A Statistical Framework for Studying Aging Phenotype Associations via Epigenetic Clocks
SARDINE is an R framework for estimating associations between epigenetic clocks and various aging phenotypes from summary statistics in epigenome-wide association studies (EWAS). Epigenetic clocks are tools that estimate biological age from DNA methylation patterns. SARDINE’s core value is that it works with publicly available summary statistics rather than requiring individual-level data — making it accessible to researchers without large raw cohorts. Last active in early November 2026, currently sitting at 1 star. Check the repo’s docs and examples before diving in.
anbai106/SleepChart: Modeling Scripts for Sleep Duration vs. 23 Biological Age Clocks
SleepChart provides R scripts for analyzing the relationship between sleep duration and 23 biological age clocks, using Generalized Additive Models (GAM — a statistical method that captures non-linear relationships). It’s a solid fit for data analysts working at the intersection of sleep and aging research. The repo includes the original analysis scripts, has 3 stars, and was last active in late October 2026. Check the repo page for license info before use.
❓ Related Questions
What’s the Human Trial Status for Elamipretide — Can It Be Used Now?
Not yet. 🚫 In this Aging Cell study , the human component was limited to in vitro experiments on cultured oocytes — not a human clinical trial. The in-vivo mouse results also can’t be directly extrapolated to humans. Elamipretide has been studied in humans for heart failure before, but there’s no registered clinical trial data available for the ovarian aging indication yet.